<DOC>
	<DOCNO>NCT01572077</DOCNO>
	<brief_summary>The purpose study evaluate pattern metabolic activity heart patient pulmonary arterial hypertension ( PAH ) . Patients PAH risk develop weakness failure right side heart.It possible relationship development heart failure way heart use energy source , sugar . This study design evaluate way heart use sugar uptake patient PAH use positron emission tomography ( PET image )</brief_summary>
	<brief_title>Rt Ventricular Substrate Metabolism Predictor Rt Heart Failure Patients With Pulmonary Arterial Hypertension</brief_title>
	<detailed_description>PAH result premature death result right ventricular dysfunction . However , substantial difference among patient tendency develop right heart failure . This study propose determine right ventricular ( RV ) change predict development right heart failure patient PAH . In addition , study aim evaluate relationship right ventricular metabolism physiologic response PAH , include : pulmonary vascular resistance , serum BNP change cardiac hypertrophy function . In conjunction hemodynamic measurement , biomarkers cardiac magnetic resonance imaging ( MRI ) ; RV metabolism evaluate ( 18F ) FTHA ( 18F ) FDG cardiac PET imaging . A cohort 20 age sex match individual serve normal control . These subject know cardiac pulmonary disease normal ventricular function estimate pulmonary pressure echocardiogram .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Familial Primary Pulmonary Hypertension</mesh_term>
	<criteria>( PATIENTS ) Patients diagnosis Category 1 pulmonary arterial hypertension due following : idiopathic , familial , associated connective tissue disease , HIV disease anorexigen use . All patient require right heart catheterization clinical management and/or diagnosis . Patients consider eligible significant coronary artery disease ( stenosis &gt; 70 % proximal mid major coronary artery ) moderate coronary artery disease ( 6070 % ) abnormal leave ventricular function ( EF &lt; 50 % ) Patients consider eligible absence current recent evidence right heart failure . No previous hospital admission requirement intravenous diuretic right heart failure within 6 month enrolment . No increase oral diuretic control fluid volume within 6 month prior enrolment No current symptom sign fluid retention right heart strain , include follow : development new ascites peripheral edema &gt; = 2+ , JVP &gt; 7 cm sternal angle right atrial pressure &gt; 14 mmHg time right heart catheterization . In addition , include small cohort 15 patient PAH current RHF . Patients know significant coronary artery disease ( define know stenosis &gt; 70 % proximal mid major artery moderate coronary artery disease ( 6070 % ) coronary artery associate leave ventricular ejection fraction &lt; 50 % . Patients diabetes mellitus require use oral hypoglycemics insulin . Implantable metal device , incompatible magnetic resonance imaging . Other contraindication magnetic resonance imaging . Normal Control Subjects : Subjects know cardiac pulmonary disease . Normal ventricular function estimate pulmonary pressure echocardiogram .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>